Cite
HARVARD Citation
Moskovich, D. et al. (2023). Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224–233]. Cancer letters. p. . [Online].